Abstract:Background A high model of end-stage liver disease (MELD) score (>30) adversely affects outcomes even if patients receive prompt liver transplantation (LT). Therefore, balanced allocation of donor grafts is indispensable to avoid random combinations of donor and recipient risk factors, which often lead to graft or recipient loss. Predictive models aimed at avoiding donor risk factors in high-MELD score recipients are urgently required to obtain satisfactory outcomes. Method Data of patients with MELD score >30 who underwent LT at three transplantation institutes between 2015 and 2018 were retrospectively reviewed. Early allograft dysfunction (EAD), length of intensive care unit (ICU) stay, and graft loss were recorded. Corresponding independent risk factors were analyzed using stepwise multivariable regression analysis. A prediction model of graft loss was developed, and discrimination and calibration were measured. Results After applying the exclusion criteria, 778 patients were enrolled. The incidence of EAD was 34.8% (271/778). Donor graft macrovesicular steatosis, graft-to-recipient weight ratio (GRWR), warm ischemia time (WIT), cold ischemia time (CIT), and ABO blood incompatibility, together with donor serum albumins, were independent predictors of EAD. The incidence of ICU stay over 10 days was 64.7% (503/778). Donor age, recipient's MELD score, Child score, and CIT were independent predictors of ICU stay. The 3-year graft survival rates (GSRs) in the training and validation cohorts were 64.2 and 59.3%, respectively. The independent predictors of graft loss were recipient's Child score, ABO blood type incompatibility, donor serum total bilirubin over 17.1 μmol/L, and cold CIT. A nomogram based on these variables was internally and externally validated and showed good performance (area under the receiver operating characteristic curve = 70.8 and 66.0%, respectively). For a recipient with a high MELD score, the avoidance of ABO blood type incompatibility and CIT ≥6 h would achieve a 3-year GSR of up to 78.4%, whereas the presence of the aforementioned risk factors would decrease the GSR to 35.4%. Conclusion The long-term prognosis of recipients with MELD scores >30 could be greatly improved by avoiding ABO blood type incompatibility and CIT ≥6 h.

Early Outcomes of Implanting Larger-Sized Grafts in Deceased Donor Liver Transplantation.

Influence of graft size matching on outcomes of infantile living donor liver transplantation

Effect of Donor Diabetes on Prognosis of Liver Transplantation in Patients with Acute-Chronic Liver Failure

Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Graft-to-recipient Weight Ratio Exerts Nonlinear Effects on Prognosis by Interacting with Donor Liver Macrosteatosis

A retrospective study investigating the risk of graft loss in living donor liver transplant cases where size mismatching is predicted from graft-to-recipient weight ratio

Liver Graft-to-Spleen Volume Ratio as a Useful Predictive Factor of the Outcomes in Living Donor Liver Transplantation: A Retrospective Study

Smaller Grafts Do Not Imply Early Recurrence in Recipients Transplanted for Hepatocellular Carcinoma: A Chinese Experience

Small graft size and hepatocellular carcinoma outcomes in living donor liver transplantation: a retrospective multicentric cohort study

Impact of Donor Diabetes Mellitus Status on Liver Transplant Outcomes in Patients with Acute-on-chronic Liver Failure

Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation

Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors

Survival after live donor versus deceased donor liver transplantation: propensity score-matched study

Outcomes of liver transplantation using moderately steatotic liver from donation after cardiac death (DCD)

Older liver grafts from donation after circulatory death are associated with impaired survival and higher incidence of biliary non-anastomotic stricture

Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35

Living Donor Liver Transplantation Using Dual Grafts: Experience and Lessons Learned from Cases Worldwide

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation

Clear Mortality Gap Caused by Graft Macrosteatosis in Chinese Patients after Cadaveric Liver Transplantation

Pre-transplant evaluation of graft volume in adult living donor liver transplantation with the right lobe: a single center experience of 100 cases

Laparoscopic Pancreaticoduodenectomy: from “standard” to “Extended”